Delivery Order SPE2DB22D1106-SPE2DB25FFAB7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- This delivery order, valued at $7,254.00, was awarded to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pregnyl 10,000 unit vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a child contract under a larger federal procurement vehicle. The award was made without a set-aside designation, indicating open competition. The place of performance is located in Conshohocken, Pennsylvania, the headquarters of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- This delivery order, valued at $2,418.00, was awarded on July 30, 2025, to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. The contract, which is not set-aside and carries a firm fixed price structure, will be performed at the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The Defense Logistics Agency (DLA), under the Department of Defense, issued this award as part of its ongoing pharmaceutical procurement...
- This federal contract award, valued at $4,784.39, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,415,725 units of Pregnyl 10,000 unit vials, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2023 and is a firm fixed-price delivery order. The contract was awarded on October 6, 2023 and does not have a set-aside designation,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 10,000-unit vials of the medication Pregnyl. The $2,418.00 contract has a performance period through June 23, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for various government...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.00, is for the supply of 10,000 unit vials of the medication Pregnyl. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 10,000 unit vials of the pharmaceutical product PREGNYL, with a ceiling value of $1,098.56 and a period of performance through April 3, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December...
- This federal contract award is for the delivery of PREGNYL 10,000 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has a ceiling value of $2,418.00 and is a Firm Fixed Price Delivery Order, with a completion date of July 9, 2025. The contract is not set aside and was competed openly. Amerisourcebergen...
- This federal contract award is for the delivery of Pregnyl 10,000 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract has a ceiling value of $1,224.83 and a completion date of September 21, 2023. It is a delivery order contract with a firm fixed price pricing type, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAB7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/28/25 |